These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 25013058)

  • 1. Australia. First, do harm reduction.
    Science; 2014 Jul; 345(6193):156-8. PubMed ID: 25013058
    [No Abstract]   [Full Text] [Related]  

  • 2. Heroin-assisted treatment in Switzerland: a case study in policy change.
    Uchtenhagen A
    Addiction; 2010 Jan; 105(1):29-37. PubMed ID: 19922519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. WHO status paper on prisons, drugs and harm reduction.
    Euro Surveill; 2005 Jul; 10(7):E050714.5. PubMed ID: 16785661
    [No Abstract]   [Full Text] [Related]  

  • 4. Supply control policy, harm reduction and context dependence.
    Weatherburn D
    Addiction; 2005 Jul; 100(7):927-8; discussion 930-2. PubMed ID: 15955006
    [No Abstract]   [Full Text] [Related]  

  • 5. Rapid scale up of harm reduction in China.
    Sullivan SG; Wu Z
    Int J Drug Policy; 2007 Mar; 18(2):118-28. PubMed ID: 17689354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The International Narcotics Control Board and HIV/AIDS.
    Csete J; Wolfe D
    GMHC Treat Issues; 2007; 21(1):4-7. PubMed ID: 17722331
    [No Abstract]   [Full Text] [Related]  

  • 7. Malaysia and harm reduction: the challenges and responses.
    Reid G; Kamarulzaman A; Sran SK
    Int J Drug Policy; 2007 Mar; 18(2):136-40. PubMed ID: 17689356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effectiveness of harm reduction in preventing HIV among injecting drug users.
    Wodak A; Maher L
    N S W Public Health Bull; 2010; 21(3-4):69-73. PubMed ID: 20513304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimating national-level syringe availability to injecting drug users and injection coverage: Switzerland, 1996-2006.
    Arnaud S; Jeannin A; Dubois-Arber F
    Int J Drug Policy; 2011 May; 22(3):226-32. PubMed ID: 21600753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Harm reduction drug policy.
    Voth EA
    Lancet Infect Dis; 2008 Sep; 8(9):528; author reply 528-9. PubMed ID: 18718436
    [No Abstract]   [Full Text] [Related]  

  • 11. HIV/AIDS in China. Changing course to break the HIV-heroin connection.
    Cohen J
    Science; 2004 Jun; 304(5676):1434-5. PubMed ID: 15178779
    [No Abstract]   [Full Text] [Related]  

  • 12. Drug substitution therapy: a new approach in preventing the spread of HIV/AIDS in Malaysia.
    Razali SM
    Trop Doct; 2008 Apr; 38(2):109-10. PubMed ID: 18453507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV and drugs: a common, common-sense agenda for 2016.
    Buse K; Albers E; Phurailatpam S
    Lancet Glob Health; 2016 May; 4(5):e292-3. PubMed ID: 27080461
    [No Abstract]   [Full Text] [Related]  

  • 14. Harm reduction in Tanzania: an urgent need for multisectoral intervention.
    McCurdy S; Kilonzo GP; Williams M; Kaaya S
    Int J Drug Policy; 2007 May; 18(3):155-9. PubMed ID: 17689361
    [No Abstract]   [Full Text] [Related]  

  • 15. The Harm Reduction Coalition.
    Clear A; Springer E; Lanier C
    Newsline People AIDS Coalit N Y; 1998 Jun; ():27-34. PubMed ID: 11367469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expanded syringe access demonstration program in New York State: an intervention to prevent HIV/AIDS transmission.
    Klein SJ; Birkhead GS; Candelas AR
    J Urban Health; 2000 Dec; 77(4):762-7. PubMed ID: 11194315
    [No Abstract]   [Full Text] [Related]  

  • 17. Harm reduction and needle exchange programmes.
    Lifson AR
    Lancet; 1998 Jun; 351(9118):1819. PubMed ID: 9635988
    [No Abstract]   [Full Text] [Related]  

  • 18. [Controlled drug consumption rooms].
    Allilaire JF; Costentin J; Goullé JP; Hamon M; Laqueille X; Lejoyeux M; Mouren MC; Olié JP; Nordmann R; Tillement JP
    Bull Acad Natl Med; 2013 Feb; 197(2):503-5. PubMed ID: 24919375
    [No Abstract]   [Full Text] [Related]  

  • 19. Transition to injection amongst opioid users in Iran: implications for harm reduction.
    Malekinejad M; Vazirian M
    Int J Drug Policy; 2012 Jul; 23(4):333-7. PubMed ID: 21996166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. UNGASS 2016 on drugs, the first challenge for HIV advocates in the post-2015 era.
    Fordham A; Tinasti K
    J Int AIDS Soc; 2014; 17(1):19274. PubMed ID: 25053452
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.